Serum NT-proBNP levels can reflect the cardiovascular status of patients with early-stage severe HFMD and may help clinicians to identify patients with worse prognosis before they develop pulmonary oedema, pulmonary haemorrhage, or heart failure. The gene discussed is NPPB; the disease is hand, foot and mouth disease.